After determining a set of set of conditions that facilitated the formation of stable complexes of siRNA, binding peptide, and endosomal release peptide, we tested the ability of these complexes to knock down Stat3 in the human breast cancer lines MDA-MB-231 (Fig 7 and S2 Fig). The gene discussed is STAT3; the disease is breast carcinoma.